All In MedTech

FDA Clearance Tracker · P960013-S114

Tendril STS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 16, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 16, 2020

Approved

Time to decision

78 days

Received Sep 29, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P960013-S114
Device name
Tendril STS
Applicant location
Sylmar, CA
Received
Sep 29, 2020
Decided
Dec 16, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P960013

Device type

Device class
Class III

Every decision under product code NVN

FDA's approval statement

As written in FDA's record.

Approval for 3T MR Conditional labeling of certain Assurity MRI and Endurity MRI models when combined with a subset (46 cm, 52 cm and 58 cm) of Tendril STS Model 2088TC leads.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.